These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association of Psoriasis With Comorbidity Development in Children With Psoriasis. Tollefson MM; Van Houten HK; Asante D; Yao X; Maradit Kremers H JAMA Dermatol; 2018 Mar; 154(3):286-292. PubMed ID: 29322175 [TBL] [Abstract][Full Text] [Related]
6. Psoriasis comorbidities: complications and benefits of immunobiological treatment. Carvalho AV; Romiti R; Souza CD; Paschoal RS; Milman LM; Meneghello LP An Bras Dermatol; 2016; 91(6):781-789. PubMed ID: 28099601 [TBL] [Abstract][Full Text] [Related]
7. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]. Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL; Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603 [TBL] [Abstract][Full Text] [Related]
8. Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis. Valenzuela F; De La Cruz C; Lecaros C; Fernández J; Hevia G; Maul LV; Thyssen JP; Vera-Kellet C; Egeberg A; Armijo D; Pizarro C; Riveros T; Correa H; Guglielmetti A; Didaskalu JA; Wu JJ; Griffiths CEM; Romiti R; Maul JT Clin Exp Dermatol; 2022 Dec; 47(12):2234-2241. PubMed ID: 35988043 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis and comorbid diseases: Implications for management. Takeshita J; Grewal S; Langan SM; Mehta NN; Ogdie A; Van Voorhees AS; Gelfand JM J Am Acad Dermatol; 2017 Mar; 76(3):393-403. PubMed ID: 28212760 [TBL] [Abstract][Full Text] [Related]
11. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries. Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P; Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669 [TBL] [Abstract][Full Text] [Related]
12. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities. Ryan C; Kirby B Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782 [TBL] [Abstract][Full Text] [Related]
16. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?]. Bessis D Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666 [TBL] [Abstract][Full Text] [Related]
17. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR). Kimball AB; Leonardi C; Stahle M; Gulliver W; Chevrier M; Fakharzadeh S; Goyal K; Calabro S; Langholff W; Menter A; Br J Dermatol; 2014 Jul; 171(1):137-47. PubMed ID: 24684204 [TBL] [Abstract][Full Text] [Related]
18. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study. Xu X; Su L; Gao Y; Ding Y PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469 [TBL] [Abstract][Full Text] [Related]